Literature DB >> 35226226

Long Non-Coding RNAs in Retinal Ganglion Cell Apoptosis.

Ningzhi Zhang1, Wenye Cao1, Xuejun He1, Yiqiao Xing1, Ning Yang2.   

Abstract

Traumatic optic neuropathy or other neurodegenerative diseases, including optic nerve transection, glaucoma, and diabetic retinopathy, can lead to progressive and irreversible visual damage. Long non-coding RNAs (lncRNAs), which belong to the family of non-protein-coding transcripts, have been linked to the pathogenesis, progression, and prognosis of these lesions. Retinal ganglion cells (RGCs) are critical for the transmission of visual information to the brain, damage to which results in visual loss. Apoptosis has been identified as one of the most essential modes of RGC death. Emerging evidence suggests that lncRNAs can regulate RGC degeneration by directly or indirectly modulating apoptosis-associated signaling pathways. This review presents a comprehensive overview of the role of lncRNAs in RGC apoptosis at transcriptional, post-transcriptional, translational, and post-translational levels, emphasizing on the potential mechanisms of action. The current limitations and future perspectives of exploring the connection between lncRNAs and RGC apoptosis have been summarized. Understanding the intricate molecular interaction network of lncRNAs and RGC apoptosis will open new avenues for the identification of novel diagnostic biomarkers, therapeutic targets, and molecules for prognostic evaluation of diseases related to RGC injury.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Long non-coding RNA; Post-transcriptional regulation; Retinal ganglion cell apoptosis; Transcriptional regulation; microRNA

Year:  2022        PMID: 35226226     DOI: 10.1007/s10571-022-01210-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  83 in total

Review 1.  The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease.

Authors:  Noel J Buckley; Rory Johnson; Chiara Zuccato; Angela Bithell; Elena Cattaneo
Journal:  Neurobiol Dis       Date:  2010-02-17       Impact factor: 5.996

Review 2.  Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease.

Authors:  Arunoday Bhan; Subhrangsu S Mandal
Journal:  ChemMedChem       Date:  2014-03-26       Impact factor: 3.466

Review 3.  Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches.

Authors:  Julia Beermann; Maria-Teresa Piccoli; Janika Viereck; Thomas Thum
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 4.  The molecular basis of retinal ganglion cell death in glaucoma.

Authors:  Mohammadali Almasieh; Ariel M Wilson; Barbara Morquette; Jorge Luis Cueva Vargas; Adriana Di Polo
Journal:  Prog Retin Eye Res       Date:  2011-12-04       Impact factor: 21.198

5.  Glaucoma risk alleles at CDKN2B-AS1 are associated with lower intraocular pressure, normal-tension glaucoma, and advanced glaucoma.

Authors:  Kathryn P Burdon; April Crawford; Robert J Casson; Alex W Hewitt; John Landers; Patrick Danoy; David A Mackey; Paul Mitchell; Paul R Healey; Jamie E Craig
Journal:  Ophthalmology       Date:  2012-04-21       Impact factor: 12.079

6.  RETRACTED: Astragaloside protects oxygen and glucose deprivation induced injury by regulation of microRNA-21 in retinal ganglion cell line RGC-5.

Authors:  He Bao; Danyu Sun; Peng Qi; Shixian Jiang
Journal:  Biomed Pharmacother       Date:  2018-11-26       Impact factor: 6.529

Review 7.  Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration.

Authors:  Sara Al Hussein Al Awamlh; Lauren K Wareham; Michael L Risner; David J Calkins
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

8.  LNCcation: lncRNA localization and function.

Authors:  Mary Catherine Bridges; Amanda C Daulagala; Antonis Kourtidis
Journal:  J Cell Biol       Date:  2021-02-01       Impact factor: 10.539

Review 9.  Beyond the RNA-dependent function of LncRNA genes.

Authors:  Tamer Ali; Phillip Grote
Journal:  Elife       Date:  2020-10-23       Impact factor: 8.140

10.  LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson's disease.

Authors:  Li-Jun Cai; Li Tu; Xiao-Mo Huang; Jia Huang; Nan Qiu; Guang-Hong Xie; Jian-Xiong Liao; Wei Du; Ying-Yue Zhang; Jin-Yong Tian
Journal:  Mol Brain       Date:  2020-09-24       Impact factor: 4.041

View more
  1 in total

Review 1.  Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma.

Authors:  Anton Dome; Maya Dymova; Vladimir Richter; Grigory Stepanov
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.